Aktienanalyse zu Houlihan Lokey Inc (HLI)HLIHoulihan Lokey Inc

Houlihan Lokey, Inc. is a global investment bank specializing in mergers and acquisitions, capital solutions, financial restructuring, and financial and valuation advisory. Its segments include Corporate Finance (CF), Financial Restructuring (FR), and Financial and Valuation Advisory (FVA). CF segment provides general financial advisory services and advice on mergers and acquisitions and capital solutions offerings. FR segment offers a range of advisory services to its clients, including: the structuring, negotiation, and confirmation of plans of reorganization; liability management transactions; corporate viability assessment, and procuring debtor-in-possession financing. FVA segment provides financial advisory and valuation services with respect to companies, debt and equity interests (including complex illiquid investments), and other types of assets and liabilities, and others. It also provides investment banking advice to clients in the insurance and wealth management sectors. It operates in the Financials sector (INVESTMENT ADVICE industry).

Houlihan Lokey Inc is a good buy right now, trading at $130.16, which is significantly below the analyst price target of $175 set by Citizens. The stock has an RSI of 61.15, indicating it is nearing overbought territory but still has room for growth. The forward P/E ratio of 15.02 suggests it is undervalued compared to its earnings potential, making it an attractive investment. However, the main risk is the recent downgrade by Morgan Stanley, which lowered its target to $165, indicating some market skepticism.

7 analysts cover HLI: 4 rate it Buy, 3 Hold and 0 Sell. The average price target is 215.50.